No Data
No Data
Jupiter Neurosciences Says Volatility 'Appears to Be Driven by Misconceptions'
Jupiter Neurosciences Addresses Market Volatility as It Remains Focused on Advancing Clinical and Commercial Milestones
Jupiter Neurosciences Signs Manufacturing Deal With Catalent Pharma for Jotrol Softgel Capsules
Express News | Jupiter Neurosciences- Under Terms, Catalent to Manufacture Clinical Batches of Jotrol for Parkinson's Study
Express News | Jupiter Neurosciences Partners With Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
Jupiter Neurosciences Partners With Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial
Unlock the Full List